325 related articles for article (PubMed ID: 17494074)
41. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
[TBL] [Abstract][Full Text] [Related]
42. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
Lavens S; Faust EA; Lu F; Jacob M; Leta M; Lieberman PM; Puré E
J Virol; 2004 Aug; 78(16):8543-51. PubMed ID: 15280463
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.
Verma D; Church TM; Swaminathan S
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13044-13055. PubMed ID: 32434920
[TBL] [Abstract][Full Text] [Related]
44. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
Ellis AL; Wang Z; Yu X; Mertz JE
J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168
[TBL] [Abstract][Full Text] [Related]
45. The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication.
Chatila T; Ho N; Liu P; Liu S; Mosialos G; Kieff E; Speck SH
J Virol; 1997 Sep; 71(9):6560-7. PubMed ID: 9261377
[TBL] [Abstract][Full Text] [Related]
46. The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site.
Zetterberg H; Jansson A; Rymo L; Chen F; Karlsson A; Klein G; Brodin B
J Gen Virol; 2002 Aug; 83(Pt 8):2007-2014. PubMed ID: 12124465
[TBL] [Abstract][Full Text] [Related]
47. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.
Bhende PM; Seaman WT; Delecluse HJ; Kenney SC
J Virol; 2005 Jun; 79(12):7338-48. PubMed ID: 15919888
[TBL] [Abstract][Full Text] [Related]
48. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.
Ragoczy T; Miller G
J Virol; 2001 Jun; 75(11):5240-51. PubMed ID: 11333906
[TBL] [Abstract][Full Text] [Related]
49. Switching of EBV cycles between latent and lytic states.
Murata T; Tsurumi T
Rev Med Virol; 2014 May; 24(3):142-53. PubMed ID: 24339346
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation.
Darr CD; Mauser A; Kenney S
J Virol; 2001 Jul; 75(13):6135-42. PubMed ID: 11390615
[TBL] [Abstract][Full Text] [Related]
51. Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection.
Nandakumar A; Uwatoko F; Yamamoto M; Tomita K; Majima HJ; Akiba S; Koriyama C
Tumour Biol; 2017 Jul; 39(7):1010428317717718. PubMed ID: 28675108
[TBL] [Abstract][Full Text] [Related]
52. Rapamycin enhances lytic replication of Epstein-Barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters.
Wang M; Wu W; Zhang Y; Yao G; Gu B
Virus Res; 2018 Jan; 244():173-180. PubMed ID: 29169830
[TBL] [Abstract][Full Text] [Related]
53. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.
Kim H; Choi H; Lee SK
J Virol; 2016 Feb; 90(3):1359-68. PubMed ID: 26581978
[TBL] [Abstract][Full Text] [Related]
55. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.
Zalani S; Holley-Guthrie E; Kenney S
J Virol; 1995 Jun; 69(6):3816-23. PubMed ID: 7745729
[TBL] [Abstract][Full Text] [Related]
56. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
Van Sciver N; Ohashi M; Nawandar DM; Pauly NP; Lee D; Makielski KR; Bristol JA; Tsao SW; Lambert PF; Johannsen EC; Kenney SC
PLoS Pathog; 2021 Nov; 17(11):e1010045. PubMed ID: 34748616
[TBL] [Abstract][Full Text] [Related]
57. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
Groves AK; Cotter MA; Subramanian C; Robertson ES
J Virol; 2001 Oct; 75(19):9446-57. PubMed ID: 11533207
[TBL] [Abstract][Full Text] [Related]
58. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
Daibata M; Speck SH; Mulder C; Sairenji T
Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
[TBL] [Abstract][Full Text] [Related]
59. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine.
Anderson AG; Gaffy CB; Weseli JR; Gorres KL
Viruses; 2019 May; 11(5):. PubMed ID: 31108875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
